Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases
worldwide and is often associated with aspects of metabolic syndrome. Despite its …
worldwide and is often associated with aspects of metabolic syndrome. Despite its …
Multiple parallel hits hypothesis in nonalcoholic fatty liver disease: revisited after a decade
Nonalcoholic fatty liver disease (NAFLD) is an epidemic liver disease, affecting
approximately one quarter of the entire population in the world.(1) This disease …
approximately one quarter of the entire population in the world.(1) This disease …
[HTML][HTML] Diabetes mellitus—Progress and opportunities in the evolving epidemic
Diabetes, a complex multisystem metabolic disorder characterized by hyperglycemia, leads
to complications that reduce quality of life and increase mortality. Diabetes pathophysiology …
to complications that reduce quality of life and increase mortality. Diabetes pathophysiology …
Oxidative stress in non-alcoholic fatty liver disease. An updated mini review
AP Delli Bovi, F Marciano, C Mandato, MA Siano… - Frontiers in …, 2021 - frontiersin.org
Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple
factors, which may partly explain why it remains still orphan of an adequate therapeutic …
factors, which may partly explain why it remains still orphan of an adequate therapeutic …
Immunological mechanisms and therapeutic targets of fatty liver diseases
Alcoholic liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD) are the two major
types of chronic liver disease worldwide. Inflammatory processes play key roles in the …
types of chronic liver disease worldwide. Inflammatory processes play key roles in the …
Acetyl CoA carboxylase inhibition reduces hepatic steatosis but elevates plasma triglycerides in mice and humans: a bedside to bench investigation
Inhibiting lipogenesis prevents hepatic steatosis in rodents with insulin resistance. To
determine if reducing lipogenesis functions similarly in humans, we developed MK-4074, a …
determine if reducing lipogenesis functions similarly in humans, we developed MK-4074, a …
[HTML][HTML] Oxidative stress in non-alcoholic fatty liver disease. An updated mini review
APD Bovi, F Marciano, C Mandato, MA Siano… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple
factors, which may partly explain why it remains still orphan of an adequate therapeutic …
factors, which may partly explain why it remains still orphan of an adequate therapeutic …
Role of adipose tissue insulin resistance in the natural history of type 2 diabetes: results from the San Antonio Metabolism Study
In the transition from normal glucose tolerance (NGT) to type 2 diabetes mellitus (T2DM), the
role of β-cell dysfunction and peripheral insulin resistance (IR) is well established. However …
role of β-cell dysfunction and peripheral insulin resistance (IR) is well established. However …
Non-alcoholic fatty liver disease, obesity and the metabolic syndrome
P Dietrich, C Hellerbrand - Best practice & research Clinical …, 2014 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is now recognized as the most common cause of
chronic liver disease worldwide. Its prevalence has increased to more than 30% of adults in …
chronic liver disease worldwide. Its prevalence has increased to more than 30% of adults in …
Nonalcoholic fatty liver disease pandemic fuels the upsurge in cardiovascular diseases
Cardiovascular diseases (CVDs) remain a leading cause of death worldwide. Among the
major risk factors for CVD, obesity and diabetes mellitus have received considerable …
major risk factors for CVD, obesity and diabetes mellitus have received considerable …